In a randomized trial, low-dose oral minoxidil at 2.5 mg/d showed comparable hair density gains to 5 mg/d dosing in men with androgenetic alopecia (AGA), with fewer adverse events. Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback